Stryker Shares Outstanding 2010-2023 | SYK
Stryker shares outstanding history from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Stryker shares outstanding for the quarter ending June 30, 2023 were 0.384B, a 0.44% increase year-over-year.
- Stryker 2022 shares outstanding were 0.382B, a 0.03% decline from 2021.
- Stryker 2021 shares outstanding were 0.382B, a 0.53% increase from 2020.
- Stryker 2020 shares outstanding were 0.38B, a 0.11% increase from 2019.
| Stryker Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2022 | 382 |
| 2021 | 382 |
| 2020 | 380 |
| 2019 | 380 |
| 2018 | 380 |
| 2017 | 380 |
| 2016 | 379 |
| 2015 | 381 |
| 2014 | 383 |
| 2013 | 382 |
| 2012 | 383 |
| 2011 | 390 |
| 2010 | 400 |
| 2009 | 399 |
| Stryker Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-06-30 | 384 |
| 2023-03-31 | 383 |
| 2022-12-31 | 382 |
| 2022-09-30 | 382 |
| 2022-06-30 | 382 |
| 2022-03-31 | 383 |
| 2021-12-31 | 382 |
| 2021-09-30 | 383 |
| 2021-06-30 | 382 |
| 2021-03-31 | 382 |
| 2020-12-31 | 380 |
| 2020-09-30 | 380 |
| 2020-06-30 | 376 |
| 2020-03-31 | 380 |
| 2019-12-31 | 380 |
| 2019-09-30 | 380 |
| 2019-06-30 | 380 |
| 2019-03-31 | 379 |
| 2018-12-31 | 380 |
| 2018-09-30 | 380 |
| 2018-06-30 | 380 |
| 2018-03-31 | 381 |
| 2017-12-31 | 380 |
| 2017-09-30 | 380 |
| 2017-06-30 | 380 |
| 2017-03-31 | 379 |
| 2016-12-31 | 379 |
| 2016-09-30 | 379 |
| 2016-06-30 | 379 |
| 2016-03-31 | 377 |
| 2015-12-31 | 381 |
| 2015-09-30 | 381 |
| 2015-06-30 | 381 |
| 2015-03-31 | 384 |
| 2014-12-31 | 383 |
| 2014-09-30 | 383 |
| 2014-06-30 | 383 |
| 2014-03-31 | 383 |
| 2013-12-31 | 382 |
| 2013-09-30 | 382 |
| 2013-06-30 | 381 |
| 2013-03-31 | 383 |
| 2012-12-31 | 383 |
| 2012-09-30 | 383 |
| 2012-06-30 | 383 |
| 2012-03-31 | 384 |
| 2011-12-31 | 390 |
| 2011-09-30 | 388 |
| 2011-06-30 | 392 |
| 2011-03-31 | 394 |
| 2010-12-31 | 400 |
| 2010-09-30 | 398 |
| 2010-06-30 | 399 |
| 2010-03-31 | 400 |
| 2009-12-31 | 399 |
| 2009-09-30 | 400 |
| 2009-06-30 | 399 |
| 2009-03-31 | 399 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $108.343B | $18.449B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $170.325B | 22.88 |
| Medtronic (MDT) | Ireland | $106.802B | 14.95 |
| EssilorLuxottica (ESLOY) | France | $80.604B | 0.00 |
| Boston Scientific (BSX) | United States | $78.482B | 28.51 |
| Haleon (HLN) | United Kingdom | $37.631B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $34.769B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.417B | 16.30 |
| Terumo (TRUMY) | Japan | $20.748B | 31.53 |
| ResMed (RMD) | United States | $20.091B | 21.18 |
| Koninklijke Philips (PHG) | Netherlands | $19.121B | 16.88 |
| Baxter (BAX) | United States | $19.091B | 13.27 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.075B | 0.00 |
| Insulet (PODD) | United States | $10.871B | 96.71 |
| Bio-Rad Laboratories (BIO) | United States | $10.265B | 28.82 |
| Demant (WILYY) | Denmark | $9.182B | 0.00 |
| BellRing Brands (BRBR) | United States | $5.393B | 33.63 |
| QuidelOrtho (QDEL) | United States | $4.784B | 12.75 |
| Haemonetics (HAE) | United States | $4.567B | 25.73 |
| Envista Holdings (NVST) | United States | $4.559B | 15.46 |
| Perrigo (PRGO) | Ireland | $4.367B | 13.49 |
| Lantheus Holdings (LNTH) | United States | $4.230B | 12.49 |
| Neogen (NEOG) | United States | $4.123B | 34.04 |
| Prestige Consumer Healthcare (PBH) | United States | $2.869B | 13.82 |
| ICU Medical (ICUI) | United States | $2.806B | 19.67 |
| GN Store Nord (GNNDY) | Denmark | $2.765B | 17.91 |
| InMode (INMD) | Israel | $2.679B | 13.51 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.410B | 13.91 |
| Green Thumb Industries (GTBIF) | United States | $2.287B | 59.49 |
| AtriCure (ATRC) | United States | $1.949B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.615B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.380B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.367B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.269B | 50.00 |
| National Vision Holdings (EYE) | United States | $1.236B | 39.55 |
| Warby Parker (WRBY) | United States | $1.203B | 0.00 |
| Owens & Minor (OMI) | United States | $1.194B | 16.96 |
| AdaptHealth (AHCO) | United States | $1.171B | 29.66 |
| Quanterix (QTRX) | United States | $0.939B | 0.00 |
| Valneva SE (VALN) | France | $0.887B | 91.21 |
| VAREX IMAGING (VREX) | United States | $0.761B | 18.28 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.615B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.606B | 0.00 |
| PetIQ (PETQ) | United States | $0.586B | 31.13 |
| BioLife Solutions (BLFS) | United States | $0.572B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.535B | 10.84 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Surmodics (SRDX) | United States | $0.459B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.415B | 9.74 |
| Biote (BTMD) | United States | $0.389B | 3.57 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.306B | 17.78 |
| Zynex (ZYXI) | United States | $0.303B | 18.33 |
| Sanara MedTech (SMTI) | United States | $0.290B | 0.00 |
| MacroGenics (MGNX) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 37.63 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.257B | 9.04 |
| Quipt Home Medical (QIPT) | United States | $0.218B | 518.00 |
| Ayr Wellness (AYRWF) | United States | $0.218B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.204B | 13.31 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.167B | 0.00 |
| MariMed (MRMD) | United States | $0.160B | 23.00 |
| Jin Medical (ZJYL) | China | $0.150B | 0.00 |
| High Tide (HITI) | Canada | $0.149B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.142B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.121B | 0.00 |
| Apyx Medical (APYX) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 0.00 |
| Chimerix (CMRX) | United States | $0.092B | 0.50 |
| Cytosorbents (CTSO) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.071B | 0.00 |
| Brainsway (BWAY) | Israel | $0.069B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.069B | 14.82 |
| Bright Green (BGXX) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.049B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.043B | 0.00 |
| Societal CDMO (SCTL) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.041B | 0.00 |
| Exagen (XGN) | United States | $0.040B | 0.00 |
| Global System Dynamics (GSD) | United States | $0.037B | 0.00 |
| Minerva Surgical (UTRS) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 15.68 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Modular Medical (MODD) | United States | $0.024B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.024B | 0.00 |
| Khosla Ventures Acquisition (KVSA) | United States | $0.021B | 0.00 |
| ProSomnus (OSA) | United States | $0.016B | 0.00 |
| Vapotherm (VAPO) | United States | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.014B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.011B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.004B | 0.00 |
| Histogen (HSTO) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Akerna (KERN) | United States | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.002B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.001B | 0.00 | |
| InterCure (INCR) | Israel | $0.000B | 12.50 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
